Tigermed Acquires Frontage Laboratories - - BioPharm International

ADVERTISEMENT

Tigermed Acquires Frontage Laboratories



Hangzhou Tigermed Consulting, a provider of outsourced clinical development services across China and the Asia Pacific, has entered a definitive agreement, subject to certain closing conditions and regulatory approval, to acquire a majority position in the ownership of Frontage Laboratories for a cash payment of $50.25 million.

Headquartered in Exton, PA, Frontage provides bioanalysis, preclinical and early phase clinical studies, drug development (CMC) services, and DMPK support for biopharmaceutical organizations. The company offers a range of services from discovery through late-stage clinical trials for new, generic, and consumer product development programs. Frontage also owns Frontage Lab (Shanghai) Co, Ltd.

Frontage will continue to operate independently. Song Li will remain CEO, and its current management team will remain in place after the transaction.

Source: Frontage Laboratories

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines

Click here